Pharmacogenomics in psychiatry: clinical issues to be considered

Pharmacogenomics approach in psychiatry disorders

Psychiatric disorders are important health issues in the world, and their management is facing some serious challenges. Drugs that are widely used in the treatment of psychiatric disorders, including antidepressants, antipsychotics, and mood stabilizers, are often associated with many side effects and are adequately effective only in a small proportion of patients. Many factors, including genet...

Protein identification by mass spectrometry: issues to be considered.

During the past two decades, mass spectrometry has become established as the primary method for protein identification from complex mixtures of biological origin. This is largely attributable to the fortunate coincidence of instrumental advances that allow routine analysis of minute amounts (typically femtomoles) of involatile, polar compounds such as peptides in complex mixtures, with the rapi...

Elucidation of the Factors to Be Considered in Ayurvedic Clinical

The theory and practice of Ayurveda are based on the doctrine of tridosa, according to which disease states spring from the disturbance of the three factors vata, pitta and kapha. Being a wholistic medical system Ayurveda considers several variables in the diagnosis and treatment of diseases. This report identifies these variables in detail and highlights their clinical significance.

Staphylococcus lugdunensis; a pathogen that should be considered in Iran

Background: Staphylococcus lugdunensis is Gram-positive cocci of the staphylococcaceae family. S. lugdunensis despite having a clotting factor (wall coagulase), was classified in the coagulase negative staphylococcus group (CoNS) for lack of free coagulase. Although this bacterium is part of the human normal flora, in terms of virulence, S. lugdunensis is in second place after S. aureus. S. lug...

Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.